Condition P13A
Alzheimer disease
People with mild cognitive impairment or dementia due to Alzheimer disease.
2 randomized trials; 0 fitted analyses across 1 outcomes.
All outcomes
Each outcome is analyzed per time window and estimand, with doses kept apart (each dose) and pooled (each medicine). Analyses with too few connected trials are shown as descriptive.
CDR-SB changeprimary
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| weeks 36 to 64 (target week 52) | Not stated by the trials | Each dose separately | 1 | 2 | Descriptive only |
| weeks 36 to 64 (target week 52) | Not stated by the trials | Doses of a drug pooled | 1 | 2 | Descriptive only |